SCHEMBL19009602

SCHEMBL19009602

c1ccc(-c2cccc(-c3cc(-c4cc(-c5cc6ccccc6cn5)cc(-c5cc6ccccc6cn5)c4)cc(-c4ccc(-c5ccccn5)cc4)n3)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.47
▸ RAB9A P51151 5/20 0.46
▸ CYP19A1 P11511 1/20 0.42
▸ IDO1 P14902 1/20 0.42
▸ TDO2 P48775 1/20 0.42
▸ ABL1 P00519 1/20 0.40
▸ DHODH Q02127 1/20 0.40
▸ TGFBR1 P36897 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ TP53 P04637 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ ALPL P05186 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ ALPI P09923 1/20 0.39
▸ ALPG P10696 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CCR1 P32246 1/20 0.39
▸ HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945605 0.96 NPC1 (0.49) NPC1RAB9ACYP19A1IDO1TDO2
SCHEMBL17945880 0.93 NPC1 (0.44) NPC1RAB9ACYP19A1IDO1TDO2
SCHEMBL17343436 0.92 NPC1 (0.53) NPC1RAB9ACYP19A1ABL1DHODH
SCHEMBL17944930 0.91 NPC1 (0.54) NPC1RAB9ACYP19A1IDO1TDO2
SCHEMBL17343432 0.89 NPC1 (0.47) NPC1RAB9ACYP19A1IDO1TDO2
SCHEMBL17343439 0.88 NPC1 (0.57) NPC1RAB9ACYP19A1IDO1TDO2
SCHEMBL17944928 0.88 KDM4E (0.50) NPC1RAB9ACYP19A1DHODHTGFBR1
SCHEMBL19009559 0.88 KDM4E (0.50) NPC1RAB9ACYP19A1DHODHTGFBR1
SCHEMBL17932365 0.88 KDM4E (0.50) NPC1RAB9ACYP19A1DHODHTGFBR1
SCHEMBL21883470 0.87 TGFBR1 (0.45) NPC1RAB9ACYP19A1DHODHTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 — — US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 — — US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 — — US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 — — US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 NPC1 317/4885RAB9A 1433/4885CYP19A1 1341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback